Cardlytics (NASDAQ: CDLX) reported Q1 EPS of ($0.34), in-line with the analyst estimate of ($0.34). Revenue for the quarter came in at $53.2 million versus the consensus estimate of $51.46 million.

“We had a strong start to the year with Q1 billings and revenue exceeding our expectations. Our results reflect a continued positive trajectory in our business,” said Lynne Laube, CEO & Co-Founder of Cardlytics. “The Dosh acquisition is already proving out our acquisition thesis and we believe the upcoming Bridg acquisition has the potential to be transformational given its technology and unique position in the CDP market."

“We are extremely pleased with our results in Q1, which marked our return to year-over-year growth,” said Andy Christiansen, CFO of Cardlytics. “Our legacy business is strong and has a lot of momentum, and the acquisitions of Dosh and Bridg will not only sustain that momentum for years to come, but will also open up new avenues for future growth.”

For earnings history and earnings-related data on Cardlytics (CDLX) click here.